Larry Luxner, senior correspondent for Rare Disease Advisor, interviews Eric Olson, PhD, chief scientific advisor at Vertex Pharmaceuticals and founding chair of the molecular biology department at the University of Texas-Southwestern Medical Center. Dr. Olson is an expert on Duchenne muscular dystrophy and CRISPR gene editing technology. He will be moderating a 9-member panel on gene therapy and gene editing at the CureDuchenne Futures conference being held October 8-10, 2021.

Read the full article: CureDuchenne to Highlight Latest Developments in Gene Therapy, Editing

Continue Reading